“sanofi” Archives

in
Entry Author Date Location
Joint Biomedical Engineering Program Bridges Campuses on Tobacco Road 05/05/16 Raleigh Durham
In M&A Bonanza, AbbVie, Sanofi Throw Billions at Stemcentrx, Medivation 04/28/16 San Francisco
Advisory Panel Backs Intercept’s Liver Drug, FDA Ruling up Next 04/07/16 New York
As Rivals Make News, Intercept Heads To Daylong Hearing For Liver Drug 04/06/16 New York
Making the Price Right: Ideas To Change Drug Costs Gain Momentum 04/05/16 National
East Coast Biotech Roundup: NY Disruptors, Commense, Regeneron, & More 04/01/16 Boston
Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push 03/30/16 Texas
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
West Coast Bio Roundup: Gilead Onco Woes, Adaptive Expansion & More 03/18/16 San Diego
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Amgen Bests Sanofi-Regeneron In PCSK9 Patent Case, Losers Vow Appeal 03/16/16 New York
Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer 03/03/16 Boston
One Year Post-Launch, Yumanity Lands $45M For Yeasty Discovery 02/10/16 Boston
Warp Drive, Surface, Bamboo Cut Deals on Eve of J.P. Morgan 01/11/16 Boston
From Ambitions To Markets: Richard Kitney And More Synthetic Bio Views 01/06/16 National
Still Years From Clinic, Navitor Gets $33M And More Pharma Friends 12/18/15 Boston
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Ex-Sanofi CEO Gets $600M to Drug Hunt With Boston Pharma 11/19/15 Boston
Keeping Score, Clinical Watchdogs Push Drugmakers For More Open Data 11/17/15 National
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Idea Behind Warp Drive’s New Cancer Attack Was Hiding In Plain Sight 11/10/15 Boston
Ex-Blueprint Med CEO Resurfaces With $7.5M to Fight Genetic Blindness 11/09/15 Boston
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations 10/29/15 San Francisco
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More 10/08/15 Boston
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard 09/10/15 Boston
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round 09/08/15 Boston
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Page 2 of 9 « previous page · next page »